ShareValue scores for AHCL.NSE: Valuation 62, Quality 53, Growth 60, Health 54.

AHCL.NSE
NSE

AHCL

₹14.51(+0.55%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

7% to 17%
Valuation
62
Fair Value
Price vs Value
Quality
53
Moderate
Business Strength
Growth
60
Moderate
Revenue & Earnings
Health
54
Moderate
Financial Stability
Momentum
65
Bullish
Price Trend

Company Details

About

Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumatic therapeutics areas. The company was incorporated in 2013 and is based in Rajkot, India.

Score Analysis

AI Investment Thesis

Data as of:Aug 18, 2026
|
Last calculated:Aug 18, 2026